课题基金 / 基金详情

The Beta-3 adrenergic receptor has a possibility to improve the mortality with sepsis-induced cardiac dysfunction by regulating cardiac metabolism.

The Beta-3 adrenergic receptor has a possibility to improve the mortality with sepsis-induced cardiac dysfunction by regulating cardiac metabolism.
Beta-3 肾上腺素能受体有可能通过调节心脏代谢来改善脓毒症引起的心脏功能障碍的死亡率。
批准号:
18K16505
负责人:
KAWAGUCHI SATOSHI
金额:
$2.66万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Early-Career Scientists
财政年份:
2018
资助国家:
日本
项目状态:
已结题
起止时间:
2018-04-01 至 2020-03-31

项目摘要

项目成果

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
期刊论文(7)
专著(0)
科研奖励(0)
会议论文
Endotoxin Induced Cardiac Metabolic Shift is Controlled Through the Regulation of Fatty Acid Oxidation by a Beta-3 Adrenergic Receptor
通过 Beta-3 肾上腺素受体调节脂肪酸氧化来控制内毒素诱导的心脏代谢转变
DOI: --
发表时间: 2018
期刊:
影响因子: --
作者: [Satoshi Kawaguchi, Motoi Okada, Satoshi Fujita, Naoyuki Hasebe]
通讯作者: Naoyuki Hasebe
Cardiac Metabolism was Improved by Regulation of Nitric Oxide Synthase Through The Beta-3 Adrenergic Receptor in Endotoxin-induced Failing Heart
在内毒素引起的心力衰竭中,通过 Beta-3 肾上腺素能受体调节一氧化氮合酶,改善心脏代谢
DOI: --
发表时间: 2019
期刊:
影响因子: --
作者: [Satoshi Kawaguchi, Motoi Okada, Satoshi Fujita, Naoyuki Hasebe]
通讯作者: Naoyuki Hasebe
Beta-3 adrenergic receptor blockade reduces mortality with septic cardiomyopathy by saving cardiac energy metabolism and mitochondrial function
Beta-3 肾上腺素能受体阻断可通过节省心脏能量代谢和线粒体功能来降低脓毒症心肌病的死亡率
DOI: --
发表时间: 2018
期刊:
影响因子: --
作者: [Satoshi Kawaguchi, Motoi Okada, Satoshi Fujita, Naoyuki Hasebe]
通讯作者: Naoyuki Hasebe
The Blockade of Beta-3 Adrenergic Receptor Improves Prognosis of the Sepsis-Related Heart Failure by Stabilization of the Heart Metabolism
阻断 Beta-3 肾上腺素能受体通过稳定心脏代谢改善脓毒症相关心力衰竭的预后
DOI: --
发表时间: 2018
期刊:
影响因子: --
作者: [Satoshi Kawaguchi, Motoi Okada, Satoshi Fujita, Naoyuki Hasebe]
通讯作者: Naoyuki Hasebe
共 6 条